BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$2.72 +0.00 (+0.00%)
As of: Oct 21, 2026 · 2:43 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Receivables (2024 - 2026)

Updated

BridgeBio Oncology Therapeutics (BBOT) reported Receivables of $661,000 for Q2 2026, up 352.7% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Receivables (2024 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Oncology Therapeutics posted Receivables of $386,000, up 376.5% from FY2024.

  • By year, Receivables came in at $81,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 19.05 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn 13.82 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn 12.49 Bn
10 BridgeBio Oncology Therapeutics 217.75 Mn -1.15 Bn - 661,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 661,000.00
Mar 31, 2026 146,000.00
Dec 31, 2025 386,000.00
Dec 31, 2024 81,000.00
API Access

BridgeBio Oncology Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=BBOT&period=max&api_key=YOUR_API_KEY